Target intelligence / Profile preview

Protein mab-21-like 2 (MAB21L2)

Target
MAB21L2
Molecular classification
Other (member of the male-abnormal 21-like protein family), Transcriptional regulator (transcriptional repressor), developmentally important nuclear protein
01

Overview

Protein mab-21-like 2 (MAB21L2) is a member of the male-abnormal 21-like (MAB21L) protein family implicated in vertebrate embryonic development, notably in eye formation, neural tube development, and axis specification[2][3]. The protein localizes primarily to the nucleus, where it acts as a transcriptional repressor, physically interacting with SMAD1 and modulating the TGF-β/BMP4 signaling pathways during development[3]. Pathogenic variants in the *MAB21L2* gene cause a spectrum of ocular developmental defects including microphthalmia, anophthalmia, and coloboma, and can result in syndromic malformations (e.g., MCOPS14)[2]. While structurally related to nucleotidyltransferases, MAB21L2’s enzymatic activity remains unproven; evidence supports a role in transcriptional regulation rather than classical enzyme activity[2][3]. Several protein partners, including heat shock proteins (HSPA5, HSPA8), have been identified as interactors, potentially impacting protein homeostasis in normal and mutant states[2]. There are currently no therapeutic drugs targeting MAB21L2, and its main disease relevance is as a cause of developmental syndromes.

Other names
MAB21L2MCOPS14MCSKS14Protein mab-21-like 2mab-21-like 2
02

Mechanism of action

null

03

Biological functions

Embryonic developmentEye morphogenesisNeural tube formationTranscriptional regulation (repressor/co-repressor activity)Antagonism of TGF-β/BMP4 signaling (via interaction with SMAD1)Potential involvement in RNA bindingEye and neural developmentBMP/TGF-β signaling modulation
04

Disease associations

Ocular developmental disorders (microphthalmia, anophthalmia, coloboma)Congenital malformations (including syndromes such as MCOPS14 and MCSKS14)Potential developmental defects of the central nervous systemCongenital eye and neural malformations
05

Safety considerations

Pathogenic mutations, especially dominant missense mutations (e.g., affecting Arg51), are associated with severe congenital eye malformations. The functional role in development suggests that modulation could carry developmental and embryonic safety risks[2][3].High developmental risk with pathogenic mutations.

Beyond the preview

Go deeper on Protein mab-21-like 2 (MAB21L2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein mab-21-like 2 (MAB21L2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call